Diabetes Management in Primary Care


HbA1c Medicare rebate commencing November 1, 2021


Improve the outcomes for patients living with diabetes through HbA1c diagnosis and monitoring


Point-of-care (POC) HbA1c testing improves diabetes management in primary care settings.


Compared with laboratory testing, POC HbA1c testing has been shown to significantly enhance clinical decision-making in terms of
appropriate intensification of therapy, improves medication adherence and patient satisfaction.1,2,3,4

cobas b 101

Roche is your partner in diabetes management solutions.


Simple and easy sample collection in your practice with on the spot results allow you and your patient to proceed to treatment with confidence and speed.


Let us help equip your practice in preparation for the Hba1c rebate.


Register your interest for our upcoming AGPAL webinar series

Learn how to leverage HbA1c diagnosis and monitoring at the Point of Care to significantly improve the outcomes for your patients living with diabetes, and how to prepare your practice for the upcoming rebate.

You will also receive Continuing Professional Development (CPD) points for RACGP, AAPM and APNA for your attendance, as well as an electronic certificate of attendance for CPD recognition.

Unable to make an upcoming webinar or missed a previous one? All webinars are recorded!

Please ensure to register your interest below to receive more information.

Diabetes Management in Primary Care

HbA1c rebate available from November 1, 2021

The Australian Government is investing $2.1 million over four years, making it easier for Australians with diabetes to monitor their condition.

Contact us to register your interest in the upcoming AGPAL webinar series or to find out more about how to get your practice ready for the Hba1c rebate


Form Successfully Submitted!
Thank you for your submission!
Form Successfully Submitted!
Thank you for your submission!
  1. Miller, C.D., Barnes, C.S., Phillips, L.S., Ziemer, D.C., Gallina, D.L. et al. (2003). Rapid A1c availability improves clinical decision-making in an urban primary care clinic. Diabetes Care 26, 1158-1163.
  2. Thaler, L.M., Ziemer, D.C., Gallina, D.L., Cook, C.B., Dunbar, V.G. et al. (1999). Diabetes in urban African-Americans. XVII. Availability of rapid HbA1c measurements enhances clinical decision-making. Diabetes Care 22, 1415-1421.
  3. Gialamas, A., Yelland, L.N., Ryan, P., Willson, K., Laurence, C.O. et al. (2009). Does point-of-care testing lead to the same or better adherence to medication? A randomised controlled trial: the PoCT in General Practice Trial. Med J Aust 191, 487-491.
  4. Laurence, C.O., Gialamas, A., Bubner, T., Yelland, L., Willson, K. et al. (2010). Patient satisfaction with point-of-care testing in general practice. Br J Gen Pract 60, e98-104.